AU6166396A - Complexes of modified lymphotoxins as pharmaceutical prepara tions - Google Patents
Complexes of modified lymphotoxins as pharmaceutical prepara tionsInfo
- Publication number
- AU6166396A AU6166396A AU61663/96A AU6166396A AU6166396A AU 6166396 A AU6166396 A AU 6166396A AU 61663/96 A AU61663/96 A AU 61663/96A AU 6166396 A AU6166396 A AU 6166396A AU 6166396 A AU6166396 A AU 6166396A
- Authority
- AU
- Australia
- Prior art keywords
- lymphotoxins
- complexes
- modified
- pharmaceutical prepara
- prepara tions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47607495A | 1995-06-07 | 1995-06-07 | |
US476074 | 1995-06-07 | ||
PCT/US1996/009773 WO1996040774A1 (en) | 1995-06-07 | 1996-06-06 | Complexes of modified lymphotoxins as pharmaceutical preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6166396A true AU6166396A (en) | 1996-12-30 |
Family
ID=23890401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU61663/96A Abandoned AU6166396A (en) | 1995-06-07 | 1996-06-06 | Complexes of modified lymphotoxins as pharmaceutical prepara tions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6166396A (en) |
WO (1) | WO1996040774A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6599719B2 (en) * | 1994-11-07 | 2003-07-29 | Human Genome Sciences, Inc. | Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha |
WO1999012965A2 (en) * | 1997-09-12 | 1999-03-18 | Biogen, Inc. | April- a novel protein with growth effects |
WO1999012964A2 (en) * | 1997-09-12 | 1999-03-18 | Biogen, Inc. | Kay - a novel immune system protein |
WO1999023105A1 (en) * | 1997-11-03 | 1999-05-14 | Human Genome Sciences, Inc. | Vegi, an inhibitor of angiogenesis and tumor growth |
AR025984A1 (en) * | 1999-10-07 | 2002-12-26 | Maxygen Aps | SIMPLE CHAIN OLIGOMERIC POLYPEPTIDES |
AU2002223032A1 (en) * | 2000-10-26 | 2002-05-06 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Hetero-oligomeric compounds derived from the tnf cytokine superfamily and their use |
WO2007054658A1 (en) * | 2005-11-14 | 2007-05-18 | King's College London | Control of immune responses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU692146B2 (en) * | 1990-06-27 | 1998-06-04 | Biogen Idec Ma Inc. | Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
ES2157889T3 (en) * | 1990-06-27 | 2001-09-01 | Biogen Inc | COMPLEX SURFACE LYMPHOTOXIN. |
-
1996
- 1996-06-06 WO PCT/US1996/009773 patent/WO1996040774A1/en active Application Filing
- 1996-06-06 AU AU61663/96A patent/AU6166396A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996040774A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6216296A (en) | Pharmaceutical compositions | |
AU6995396A (en) | Pharmaceutical formulation | |
AUPN411195A0 (en) | Medicinal composition | |
AUPN605795A0 (en) | Analgesic pharmaceutical composition | |
AU6011496A (en) | Improved pharmaceutical compositions for gene therapy | |
AU7572196A (en) | Pharmaceutical formulations | |
AU7590096A (en) | Drug composition | |
AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
AU6973396A (en) | Pharmaceutical formulation | |
AU6904896A (en) | Pharmaceutical compounds | |
AU6165196A (en) | Stable formulations of mhc-peptide complexes | |
AU7000796A (en) | Heteroaryl-substituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
AU5155096A (en) | Pharmaceutical composition | |
EP0747346A3 (en) | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics | |
AU5274096A (en) | Pharmaceutical compositions | |
AU6835996A (en) | Pyridinium derivatives and pharmaceutical compositions containing them | |
AU2531295A (en) | Pharmaceutical composition | |
AU7582696A (en) | Pharmaceutical formulation | |
AU5326298A (en) | Pharmaceutical compositions containing N-sulphonylindoline derivatives | |
AU6166396A (en) | Complexes of modified lymphotoxins as pharmaceutical prepara tions | |
AU1475595A (en) | Pharmaceutical preparation | |
AUPN727595A0 (en) | Therapeutic compositions | |
AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them | |
AU6875096A (en) | Pharmaceutical composition with trypanocidal properties |